Derivation of vascular endothelial cells from human embryonic stem cells under GMP-compliant conditions: Towards clinical studies in ischaemic disease

Journal of Cardiovascular Translational Research

Volumn 5, Issue 5, 2012, Pages 605-617

  Kaupisch, A ^a   Kennedy, L ^b   Stelmanis, V ^b   Tye, B ^b   Kane, N M ^a   Mountford, J C ^a   Courtney, A ^b   Baker, A H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Roslin Cells Limited   (United Kingdom)

Author keywords

Differentiation; EC; EPC; GMP; hESC; Roslin Cells; Vascular endothelial cells

Indexed keywords

CADHERIN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; MATRIGEL; TRANSCRIPTION FACTOR NANOG; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; LEUKOCYTE ANTIGEN; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ARTICLE; BLOOD FLOW; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRUCTURE; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL STUDY; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; CULTURE MEDIUM; DERIVATIZATION; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FEEDER CELL; FLOW CYTOMETRY; GOOD MANUFACTURING PRACTICE; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN CELL; ISCHEMIA; MONOLAYER CULTURE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; VASCULAR ENDOTHELIUM; BIOTECHNOLOGY; CELL LINE; CELL LINEAGE; CULTURE TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; STANDARD; TIME; TRANSPLANTATION;

ANTIGENS, CD; ANTIGENS, CD31; BIOLOGICAL MARKERS; BIOTECHNOLOGY; CADHERINS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; TIME FACTORS;

EID: 84874119052     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9379-2     Document Type: Article

References (39)

1. Gupta, R.; Losordo, D. W. (2011). Cell therapy for critical limb ischemia: Moving forward one step at a time. Circulation Cardiovascular Interventions, 4(1), 2-5.
2. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145-1147.
3. Reubinoff, B. E.; Pera, M. F.; Fong, C. Y.; Trounson, A.; Bongso, A. (2000). Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nature Biotechnology, 18(4), 399-404.
4. Wang, L.; Li, L.; Shojaei, F.; Levac, K.; Cerdan, C.; Menendez, P.; Martin, T.; Rouleau, A.; Bhatia, M. (2004). Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity, 21(1), 31-41.
5. Levenberg, S.; Golub, J. S.; Amit, M.; Itskovitz-Eldor, J.; Langer, R. (2002). Endothelial cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 99(7), 4391-4396.
6. Lu, S. J.; Feng, Q.; Caballero, S.; Chen, Y.; Moore, M. A.; Grant, M. B.; Lanza, R. (2007). Generation of functional hemangioblasts from human embryonic stem cells. Nature Methods, 4(6), 501-509.
7. Chen, S. S.; Fitzgerald, W.; Zimmerberg, J.; Kleinman, H. K.; Margolis, L. (2007). Cell-cell and cell-extracellular matrix interactions regulate embryonic stem cell differentiation. Stem Cells, 25(3), 553-561.
8. Li, Z.; Suzuki, Y.; Huang, M.; Cao, F.; Xie, X.; Connolly, A. J.; Yang, P. C.; Wu, J. C. (2008). Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells, 26(4), 864-873.
9. Kaufman, D. S.; Hanson, E. T.; Lewis, R. L.; Auerbach, R.; Thomson, J. A. (2001). Hematopoietic colony-forming cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 98(19), 10716-10721.
10. Wang, Z. Z.; Au, P.; Chen, T.; Shao, Y.; Daheron, L. M.; Bai, H.; Arzigian, M.; Fukumura, D.; Jain, R. K.; Scadden, D. T. (2007). Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nature Biotechnology, 25(3), 317-318.
11. Vodyanik, M. A.; Bork, J. A.; Thomson, J. A.; Slukvin, I. I. (2005). Human embryonic stem cell-derived CD34+ cells: Efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood, 105(2), 617-626.
12. Lagarkova, M. A.; Volchkov, P. Y.; Philonenko, E. S.; Kiselev, S. L. (2008). Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes. Cell Cycle, 7(18), 2929-2935.
13. Prado-Lopez, S.; Conesa, A.; Arminan, A.; Martinez-Losa, M.; Escobedo-Lucea, C.; Gandia, C.; Tarazona, S.; Melguizo, D.; Blesa, D.; Montaner, D.; Sanz-Gonzalez, S.; Sepulveda, P.; Gotz, S.; O'Connor, J. E.; Moreno, R.; Dopazo, J.; Burks, D. J.; Stojkovic, M. (2010). Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells, 28(3), 407-418.
14. Nourse, M. B.; Halpin, D. E.; Scatena, M.; Mortisen, D. J.; Tulloch, N. L.; Hauch, K. D.; Torok-Storb, B.; Ratner, B. D.; Pabon, L.; Murry, C. E. (2009). VEGF induces differentiation of functional endothelium from human embryonic stem cells: Implications for tissue engineering. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(1), 80-89.
15. James, D.; Nam, H. S.; Seandel, M.; Nolan, D.; Janovitz, T.; Tomishima, M.; Studer, L.; Lee, G.; Lyden, D.; Benezra, R.; Zaninovic, N.; Rosenwaks, Z.; Rabbany, S. Y.; Rafii, S. (2010). Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nature Biotechnology, 28(2), 161-166.
16. Cuende, N.; Izeta, A. (2010). Clinical translation of stem cell therapies: A bridgeable gap. Cell Stem Cell, 6(6), 508-512.
17. Hyun, I.; Lindvall, O.; Ahrlund-Richter, L.; Cattaneo, E.; Cavazzana-Calvo, M.; Cossu, G.; De Luca, M.; Fox, I. J.; Gerstle, C.; Goldstein, R. A.; Hermeren, G.; High, K. A.; Kim, H. O.; Lee, H. P.; Levy-Lahad, E.; Li, L.; Lo, B.; Marshak, D. R.; McNab, A.; Munsie, M.; Nakauchi, H.; Rao, M.; Rooke, H. M.; Valles, C. S.; Srivastava, A.; Sugarman, J.; Taylor, P. L.; Veiga, A.; Wong, A. L.; Zoloth, L.; Daley, G. Q. (2008). New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell, 3(6), 607-609.
18. Kane, N. M.; Meloni, M.; Spencer, H. L.; Craig, M. A.; Strehl, R.; Milligan, G.; Houslay, M. D.; Mountford, J. C.; Emanueli, C.; Baker, A. H. (2010). Derivation of endothelial cells from human embryonic stem cells by directed differentiation: Analysis of microRNA and angiogenesis in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(7), 1389-1397.
19. Kane, N. M.; Howard, L.; Descamps, B.; Meloni, M.; McClure, J.; Lu, R.; McCahill, A.; Breen, C.; Mackenzie, R. M.; Delles, C.; Mountford, J. C.; Milligan, G.; Emanueli, C.; Baker, A. H. (2012). Role of MicroRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells, 30(4), 643-654.
20. Huang, N. F.; Niiyama, H.; Peter, C.; De, A.; Natkunam, Y.; Fleissner, F.; Li, Z.; Rollins, M. D.; Wu, J. C.; Gambhir, S. S.; Cooke, J. P. (2010). Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol, 30(5), 984-991.
21. Dar, A.; Domev, H.; Ben-Yosef, O.; Tzukerman, M.; Zeevi-Levin, N.; Novak, A.; Germanguz, I.; Amit, M.; Itskovitz-Eldor, J. (2012). Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation, 125(1), 87-99.
22. Cho, S. W.; Moon, S. H.; Lee, S. H.; Kang, S. W.; Kim, J.; Lim, J. M.; Kim, H. S.; Kim, B. S.; Chung, H. M. (2007). Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation, 116(21), 2409-2419.
23. Sone, M.; Itoh, H.; Yamahara, K.; Yamashita, J. K.; Yurugi-Kobayashi, T.; Nonoguchi, A.; Suzuki, Y.; Chao, T. H.; Sawada, N.; Fukunaga, Y.; Miyashita, K.; Park, K.; Oyamada, N.; Sawada, N.; Taura, D.; Tamura, N.; Kondo, Y.; Nito, S.; Suemori, H.; Nakatsuji, N.; Nishikawa, S.; Nakao, K. (2007). Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(10), 2127-2134.
24. Evseenko, D.; Zhu, Y.; Schenke-Layland, K.; Kuo, J.; Latour, B.; Ge, S.; Scholes, J.; Dravid, G.; Li, X.; MacLellan, W. R.; Crooks, G. M. (2010). Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 107(31), 13742-13747.
25. Stratman, A. N.; Davis, M. J.; Davis, G. E. (2011). VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood, 117(14), 3709-3719.
26. Asahara, T.; Kawamoto, A. (2004). Endothelial progenitor cells for postnatal vasculogenesis. American Journal of Physiology Cell Physiology, 287(3), C572-C579.
27. Jones, E. A.; Kinsey, S. E.; English, A.; Jones, R. A.; Straszynski, L.; Meredith, D. M.; Markham, A. F.; Jack, A.; Emery, P.; McGonagle, D. (2002). Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis and Rheumatism, 46(12), 3349-3360.
28. Bi, Y.; Stuelten, C. H.; Kilts, T.; Wadhwa, S.; Iozzo, R. V.; Robey, P. G.; Chen, X. D.; Young, M. F. (2005). Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. Journal of Biological Chemistry, 280(34), 30481-30489.
29. Osafune, K.; Caron, L.; Borowiak, M.; Martinez, R. J.; Fitz-Gerald, C. S.; Sato, Y.; Cowan, C. A.; Chien, K. R.; Melton, D. A. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnology, 26(3), 313-315.
30. Albelda, S. M.; Muller, W. A.; Buck, C. A.; Newman, P. J. (1991). Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. The Journal of Cell Biology, 114(5), 1059-1068.
31. Bach, T. L.; Barsigian, C.; Chalupowicz, D. G.; Busler, D.; Yaen, C. H.; Grant, D. S.; Martinez, J. (1998). VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Experimental Cell Research, 238(2), 324-334.
32. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J. M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964-967.
33. Peichev, M.; Naiyer, A. J.; Pereira, D.; Zhu, Z.; Lane, W. J.; Williams, M.; Oz, M. C.; Hicklin, D. J.; Witte, L.; Moore, M. A.; Rafii, S. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 95(3), 952-958.
34. Estes, M. L.; Mund, J. A.; Mead, L. E.; Prater, D. N.; Cai, S.; Wang, H.; Pollok, K. E.; Murphy, M. P.; An, C. S.; Srour, E. F.; Ingram, D. A.; Jr.; Case, J. (2010). Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytometry Part A, 77(9), 831-839.
35. Masouleh, B. K.; Baraniskin, A.; Schmiegel, W.; Schroers, R. (2010). Quantification of circulating endothelial progenitor cells in human peripheral blood: Establishing a reliable flow cytometry protocol. Journal of Immunological Methods, 357(1-2), 38-42.
36. Schmidt-Lucke, C.; Fichtlscherer, S.; Aicher, A.; Tschope, C.; Schultheiss, H. P.; Zeiher, A. M.; Dimmeler, S. (2010). Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One, 5(11), e13790.
37. Lee, M. J.; Kim, J.; Lee, K. I.; Shin, J. M.; Chae, J. I.; Chung, H. M. (2011). Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy, 13(2), 165-178.
38. Moon, S. H.; Kim, J. S.; Park, S. J.; Lee, H. J.; Do, J. T.; Chung, H. M. (2011). A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation. Biomaterials, 32(27), 6445-6455.
39. Rehman, J.; Traktuev, D.; Li, J.; Merfeld-Clauss, S.; Temm-Grove, C. J.; Bovenkerk, J. E.; Pell, C. L.; Johnstone, B. H.; Considine, R. V.; March, K. L. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 109(10), 1292-1298.